Moreover, we discovered that HOTAIRM1 knockdown and a combinatorial strategy using autophagy inhibitor therapy may reprogram the tumor microenvironment for effective treatment of lenvatinib-resistant HCC. This evidence concerns the gene HOTAIRM1 and hepatocellular carcinoma.